Compound Index
AOD-9604 and Lipolysis: The Complete Research Protocol Guide
Comprehensive protocol guide for AOD-9604 (hGH fragment 176-191): β3-adrenergic/cAMP/HSL lipolytic mechanism, Heffernan 1999 DIO mouse dose-response data, adipogenesis inhibition, METABOLICA Phase 2b context, head-to-head vs hGH, reconstitution protocol with disulfide precautions, and six research design considerations.
HGH Fragment 176-191 vs AOD-9604: What's the Difference?
A research clarification on HGH Fragment 176-191 and AOD-9604 — naming conventions, structural differences, lipolytic mechanism, divergent research data, and which designation to use in your protocol.
GLP-1 Receptor Agonists: The Complete Research Landscape
A comprehensive research review of the GLP-1 receptor agonist class — semaglutide, tirzepatide, retatrutide, and liraglutide. Covers incretin physiology, GLP-1R structure and signaling, comparison table across agonists, cardiovascular outcomes data, rodent PK/PD models, and research design considerations.